Summary

The global Drug Metabolism and Pharmacokinetics (DMPK) market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
DMPK is an acronym that stands for drug metabolism and pharmacokinetics. This is a discipline that helps to identify drugs that are likely to be suitable for advancement through the drug development process. It considers how the drug is metabolized and processed by the body.
In 2025, the North America Drug Metabolism and Pharmacokinetics (DMPK) market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
The global key players of Drug Metabolism and Pharmacokinetics (DMPK) include Eurofins Discovery, Inotiv, Evotec, Sai Life Sciences, Sygnature Discovery, WuXi AppTec, Hangzhou Tigermed Consulting Co, Q2 Solutions, Jubilant Biosys, Frontage Laboratories, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of revenue, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global Drug Metabolism and Pharmacokinetics (DMPK) market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
Eurofins Discovery
Inotiv
Evotec
Sai Life Sciences
Sygnature Discovery
WuXi AppTec
Hangzhou Tigermed Consulting Co
Q2 Solutions
Jubilant Biosys
Frontage Laboratories
Invitrocue
Creative Biolabs
CrownBioscience
Agilent
H3D
LABCORP
Bioduro-Sundia
Allucent
Segment by Type
Small Molecules
Biologics
Segment by Application
Biopharmaceutical Companies
Government and Academic Institutes
Others
By Region
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Markets
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of Drug Metabolism and Pharmacokinetics (DMPK) market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Drug Metabolism and Pharmacokinetics (DMPK) value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Small Molecules
1.2.3 Biologics
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Biopharmaceutical Companies
1.3.3 Government and Academic Institutes
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Revenue, by Region (2021-2026)
2.4 Global Drug Metabolism and Pharmacokinetics (DMPK) Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Drug Metabolism and Pharmacokinetics (DMPK) Market Size and Prospective (2021-2032)
2.5.2 Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size and Prospective (2021-2032)
2.5.3 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Market Size and Prospective (2021-2032)
2.5.4 Latin America Drug Metabolism and Pharmacokinetics (DMPK) Market Size and Prospective (2021-2032)
2.5.5 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size and Prospective (2021-2032)

3 Breakdown Data by Type
3.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Historical Market Size by Type (2021-2026)
3.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Drug Metabolism and Pharmacokinetics (DMPK)

4 Breakdown Data by Application
4.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Historical Market Size by Application (2021-2026)
4.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Drug Metabolism and Pharmacokinetics (DMPK) Applications

5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Drug Metabolism and Pharmacokinetics (DMPK) Players by Revenue (2021-2026)
5.1.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Drug Metabolism and Pharmacokinetics (DMPK) Revenue
5.4 Global Drug Metabolism and Pharmacokinetics (DMPK) Market Concentration Analysis
5.4.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Drug Metabolism and Pharmacokinetics (DMPK) Revenue in 2025
5.5 Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK) Head Offices and Areas Served
5.6 Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK), Product and Application
5.7 Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK), Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Drug Metabolism and Pharmacokinetics (DMPK) Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Type (2021-2026)
6.1.2.2 North America Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Application (2021-2026)
6.1.3.2 North America Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Application (2021-2026)
6.1.4 North America Drug Metabolism and Pharmacokinetics (DMPK) Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Drug Metabolism and Pharmacokinetics (DMPK) Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Type (2021-2026)
6.2.2.2 Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Application (2021-2026)
6.2.3.2 Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Application (2021-2026)
6.2.4 Europe Drug Metabolism and Pharmacokinetics (DMPK) Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Revenue by Company (2021-2026)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Type (2021-2026)
6.3.2.2 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Type (2021-2026)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Application (2021-2026)
6.3.3.2 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Application (2021-2026)
6.3.4 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Major Customers
6.3.5 Asia-Pacific Market Trends and Opportunities
6.4 Latin America Market: Players, Segments, Downstream and Major Customers
6.4.1 Latin America Drug Metabolism and Pharmacokinetics (DMPK) Revenue by Company (2021-2026)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Type (2021-2026)
6.4.2.2 Latin America Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Type (2021-2026)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Application (2021-2026)
6.4.3.2 Latin America Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Application (2021-2026)
6.4.4 Latin America Drug Metabolism and Pharmacokinetics (DMPK) Major Customers
6.4.5 Latin America Market Trends and Opportunities
6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Revenue by Company (2021-2026)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Type (2021-2026)
6.5.2.2 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Type (2021-2026)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Application (2021-2026)
6.5.3.2 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Application (2021-2026)
6.5.4 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Major Customers
6.5.5 Middle East & Africa Market Trends and Opportunities

7 Key Player Profiles
7.1 Eurofins Discovery
7.1.1 Eurofins Discovery Company Details
7.1.2 Eurofins Discovery Business Overview
7.1.3 Eurofins Discovery Drug Metabolism and Pharmacokinetics (DMPK) Introduction
7.1.4 Eurofins Discovery Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
7.1.5 Eurofins Discovery Recent Development
7.2 Inotiv
7.2.1 Inotiv Company Details
7.2.2 Inotiv Business Overview
7.2.3 Inotiv Drug Metabolism and Pharmacokinetics (DMPK) Introduction
7.2.4 Inotiv Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
7.2.5 Inotiv Recent Development
7.3 Evotec
7.3.1 Evotec Company Details
7.3.2 Evotec Business Overview
7.3.3 Evotec Drug Metabolism and Pharmacokinetics (DMPK) Introduction
7.3.4 Evotec Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
7.3.5 Evotec Recent Development
7.4 Sai Life Sciences
7.4.1 Sai Life Sciences Company Details
7.4.2 Sai Life Sciences Business Overview
7.4.3 Sai Life Sciences Drug Metabolism and Pharmacokinetics (DMPK) Introduction
7.4.4 Sai Life Sciences Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
7.4.5 Sai Life Sciences Recent Development
7.5 Sygnature Discovery
7.5.1 Sygnature Discovery Company Details
7.5.2 Sygnature Discovery Business Overview
7.5.3 Sygnature Discovery Drug Metabolism and Pharmacokinetics (DMPK) Introduction
7.5.4 Sygnature Discovery Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
7.5.5 Sygnature Discovery Recent Development
7.6 WuXi AppTec
7.6.1 WuXi AppTec Company Details
7.6.2 WuXi AppTec Business Overview
7.6.3 WuXi AppTec Drug Metabolism and Pharmacokinetics (DMPK) Introduction
7.6.4 WuXi AppTec Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
7.6.5 WuXi AppTec Recent Development
7.7 Hangzhou Tigermed Consulting Co
7.7.1 Hangzhou Tigermed Consulting Co Company Details
7.7.2 Hangzhou Tigermed Consulting Co Business Overview
7.7.3 Hangzhou Tigermed Consulting Co Drug Metabolism and Pharmacokinetics (DMPK) Introduction
7.7.4 Hangzhou Tigermed Consulting Co Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
7.7.5 Hangzhou Tigermed Consulting Co Recent Development
7.8 Q2 Solutions
7.8.1 Q2 Solutions Company Details
7.8.2 Q2 Solutions Business Overview
7.8.3 Q2 Solutions Drug Metabolism and Pharmacokinetics (DMPK) Introduction
7.8.4 Q2 Solutions Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
7.8.5 Q2 Solutions Recent Development
7.9 Jubilant Biosys
7.9.1 Jubilant Biosys Company Details
7.9.2 Jubilant Biosys Business Overview
7.9.3 Jubilant Biosys Drug Metabolism and Pharmacokinetics (DMPK) Introduction
7.9.4 Jubilant Biosys Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
7.9.5 Jubilant Biosys Recent Development
7.10 Frontage Laboratories
7.10.1 Frontage Laboratories Company Details
7.10.2 Frontage Laboratories Business Overview
7.10.3 Frontage Laboratories Drug Metabolism and Pharmacokinetics (DMPK) Introduction
7.10.4 Frontage Laboratories Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
7.10.5 Frontage Laboratories Recent Development
7.11 Invitrocue
7.11.1 Invitrocue Company Details
7.11.2 Invitrocue Business Overview
7.11.3 Invitrocue Drug Metabolism and Pharmacokinetics (DMPK) Introduction
7.11.4 Invitrocue Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
7.11.5 Invitrocue Recent Development
7.12 Creative Biolabs
7.12.1 Creative Biolabs Company Details
7.12.2 Creative Biolabs Business Overview
7.12.3 Creative Biolabs Drug Metabolism and Pharmacokinetics (DMPK) Introduction
7.12.4 Creative Biolabs Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
7.12.5 Creative Biolabs Recent Development
7.13 CrownBioscience
7.13.1 CrownBioscience Company Details
7.13.2 CrownBioscience Business Overview
7.13.3 CrownBioscience Drug Metabolism and Pharmacokinetics (DMPK) Introduction
7.13.4 CrownBioscience Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
7.13.5 CrownBioscience Recent Development
7.14 Agilent
7.14.1 Agilent Company Details
7.14.2 Agilent Business Overview
7.14.3 Agilent Drug Metabolism and Pharmacokinetics (DMPK) Introduction
7.14.4 Agilent Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
7.14.5 Agilent Recent Development
7.15 H3D
7.15.1 H3D Company Details
7.15.2 H3D Business Overview
7.15.3 H3D Drug Metabolism and Pharmacokinetics (DMPK) Introduction
7.15.4 H3D Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
7.15.5 H3D Recent Development
7.16 LABCORP
7.16.1 LABCORP Company Details
7.16.2 LABCORP Business Overview
7.16.3 LABCORP Drug Metabolism and Pharmacokinetics (DMPK) Introduction
7.16.4 LABCORP Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
7.16.5 LABCORP Recent Development
7.17 Bioduro-Sundia
7.17.1 Bioduro-Sundia Company Details
7.17.2 Bioduro-Sundia Business Overview
7.17.3 Bioduro-Sundia Drug Metabolism and Pharmacokinetics (DMPK) Introduction
7.17.4 Bioduro-Sundia Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
7.17.5 Bioduro-Sundia Recent Development
7.18 Allucent
7.18.1 Allucent Company Details
7.18.2 Allucent Business Overview
7.18.3 Allucent Drug Metabolism and Pharmacokinetics (DMPK) Introduction
7.18.4 Allucent Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
7.18.5 Allucent Recent Development

8 Drug Metabolism and Pharmacokinetics (DMPK) Market Dynamics
8.1 Drug Metabolism and Pharmacokinetics (DMPK) Industry Trends
8.2 Drug Metabolism and Pharmacokinetics (DMPK) Market Drivers
8.3 Drug Metabolism and Pharmacokinetics (DMPK) Market Challenges
8.4 Drug Metabolism and Pharmacokinetics (DMPK) Market Restraints

9 Research Findings and Conclusion

10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market Drug Metabolism and Pharmacokinetics (DMPK) Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global Drug Metabolism and Pharmacokinetics (DMPK) Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global Drug Metabolism and Pharmacokinetics (DMPK) Revenue Share by Region (2021-2026)
Table 6. Global Drug Metabolism and Pharmacokinetics (DMPK) Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global Drug Metabolism and Pharmacokinetics (DMPK) Revenue Share Forecast by Region (2027-2032)
Table 8. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Revenue, by Type (2021-2026)
Table 10. Global Drug Metabolism and Pharmacokinetics (DMPK) Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Revenue, by Application (2021-2026)
Table 15. Global Drug Metabolism and Pharmacokinetics (DMPK) Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in Drug Metabolism and Pharmacokinetics (DMPK) Applications
Table 18. Global Drug Metabolism and Pharmacokinetics (DMPK) Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Players (2021-2026)
Table 20. Global Top Drug Metabolism and Pharmacokinetics (DMPK) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Metabolism and Pharmacokinetics (DMPK) as of 2025)
Table 21. Ranking of Global Top Drug Metabolism and Pharmacokinetics (DMPK) Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Drug Metabolism and Pharmacokinetics (DMPK) Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK), Headquarters and Area Served
Table 24. Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK), Product and Application
Table 25. Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK), Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Drug Metabolism and Pharmacokinetics (DMPK) Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Revenue, by Company (2021-2026)
Table 29. North America Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe Drug Metabolism and Pharmacokinetics (DMPK) Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Revenue, by Company (2021-2026)
Table 33. Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Application (2021-2026) & (US$ Million)
Table 35. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Revenue by Company (2021-2026) & (US$ Million)
Table 36. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Revenue, by Company (2021-2026)
Table 37. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Type (2021-2026) & (US$ Million)
Table 38. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Application (2021-2026) & (US$ Million)
Table 39. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Revenue by Company (2021-2026) & (US$ Million)
Table 40. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Revenue, by Company (2021-2026)
Table 41. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Type (2021-2026) & (US$ Million)
Table 42. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Application (2021-2026) & (US$ Million)
Table 43. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Revenue by Company (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Revenue, by Company (2021-2026)
Table 45. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Type (2021-2026) & (US$ Million)
Table 46. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Application (2021-2026) & (US$ Million)
Table 47. Eurofins Discovery Company Details
Table 48. Eurofins Discovery Business Overview
Table 49. Eurofins Discovery Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 50. Eurofins Discovery Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026) & (US$ Million)
Table 51. Eurofins Discovery Recent Development
Table 52. Inotiv Company Details
Table 53. Inotiv Business Overview
Table 54. Inotiv Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 55. Inotiv Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026) & (US$ Million)
Table 56. Inotiv Recent Development
Table 57. Evotec Company Details
Table 58. Evotec Business Overview
Table 59. Evotec Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 60. Evotec Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026) & (US$ Million)
Table 61. Evotec Recent Development
Table 62. Sai Life Sciences Company Details
Table 63. Sai Life Sciences Business Overview
Table 64. Sai Life Sciences Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 65. Sai Life Sciences Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026) & (US$ Million)
Table 66. Sai Life Sciences Recent Development
Table 67. Sygnature Discovery Company Details
Table 68. Sygnature Discovery Business Overview
Table 69. Sygnature Discovery Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 70. Sygnature Discovery Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026) & (US$ Million)
Table 71. Sygnature Discovery Recent Development
Table 72. WuXi AppTec Company Details
Table 73. WuXi AppTec Business Overview
Table 74. WuXi AppTec Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 75. WuXi AppTec Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026) & (US$ Million)
Table 76. WuXi AppTec Recent Development
Table 77. Hangzhou Tigermed Consulting Co Company Details
Table 78. Hangzhou Tigermed Consulting Co Business Overview
Table 79. Hangzhou Tigermed Consulting Co Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 80. Hangzhou Tigermed Consulting Co Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026) & (US$ Million)
Table 81. Hangzhou Tigermed Consulting Co Recent Development
Table 82. Q2 Solutions Company Details
Table 83. Q2 Solutions Business Overview
Table 84. Q2 Solutions Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 85. Q2 Solutions Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026) & (US$ Million)
Table 86. Q2 Solutions Recent Development
Table 87. Jubilant Biosys Company Details
Table 88. Jubilant Biosys Business Overview
Table 89. Jubilant Biosys Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 90. Jubilant Biosys Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026) & (US$ Million)
Table 91. Jubilant Biosys Recent Development
Table 92. Frontage Laboratories Company Details
Table 93. Frontage Laboratories Business Overview
Table 94. Frontage Laboratories Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 95. Frontage Laboratories Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026) & (US$ Million)
Table 96. Frontage Laboratories Recent Development
Table 97. Invitrocue Company Details
Table 98. Invitrocue Business Overview
Table 99. Invitrocue Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 100. Invitrocue Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026) & (US$ Million)
Table 101. Invitrocue Recent Development
Table 102. Creative Biolabs Company Details
Table 103. Creative Biolabs Business Overview
Table 104. Creative Biolabs Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 105. Creative Biolabs Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026) & (US$ Million)
Table 106. Creative Biolabs Recent Development
Table 107. CrownBioscience Company Details
Table 108. CrownBioscience Business Overview
Table 109. CrownBioscience Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 110. CrownBioscience Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026) & (US$ Million)
Table 111. CrownBioscience Recent Development
Table 112. Agilent Company Details
Table 113. Agilent Business Overview
Table 114. Agilent Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 115. Agilent Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026) & (US$ Million)
Table 116. Agilent Recent Development
Table 117. H3D Company Details
Table 118. H3D Business Overview
Table 119. H3D Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 120. H3D Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026) & (US$ Million)
Table 121. H3D Recent Development
Table 122. LABCORP Company Details
Table 123. LABCORP Business Overview
Table 124. LABCORP Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 125. LABCORP Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026) & (US$ Million)
Table 126. LABCORP Recent Development
Table 127. Bioduro-Sundia Company Details
Table 128. Bioduro-Sundia Business Overview
Table 129. Bioduro-Sundia Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 130. Bioduro-Sundia Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026) & (US$ Million)
Table 131. Bioduro-Sundia Recent Development
Table 132. Allucent Company Details
Table 133. Allucent Business Overview
Table 134. Allucent Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 135. Allucent Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026) & (US$ Million)
Table 136. Allucent Recent Development
Table 137. Drug Metabolism and Pharmacokinetics (DMPK) Market Trends
Table 138. Drug Metabolism and Pharmacokinetics (DMPK) Market Drivers
Table 139. Drug Metabolism and Pharmacokinetics (DMPK) Market Challenges
Table 140. Drug Metabolism and Pharmacokinetics (DMPK) Market Restraints
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources

List of Figures
Figure 1. Drug Metabolism and Pharmacokinetics (DMPK) Product Picture
Figure 2. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Type: 2025 vs 2032
Figure 3. Small Molecules Features
Figure 4. Biologics Features
Figure 5. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Application: 2025 vs 2032
Figure 6. Biopharmaceutical Companies
Figure 7. Government and Academic Institutes
Figure 8. Others
Figure 9. Drug Metabolism and Pharmacokinetics (DMPK) Report Years Considered
Figure 10. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 11. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Revenue, by Region: 2021 vs 2025
Figure 13. North America Drug Metabolism and Pharmacokinetics (DMPK) Revenue (US$ Million) Growth Rate (2021-2032)
Figure 14. Europe Drug Metabolism and Pharmacokinetics (DMPK) Revenue (US$ Million) Growth Rate (2021-2032)
Figure 15. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Revenue (US$ Million) Growth Rate (2021-2032)
Figure 16. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Players in 2025
Figure 19. Global Top Drug Metabolism and Pharmacokinetics (DMPK) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Metabolism and Pharmacokinetics (DMPK) as of 2025)
Figure 20. The Top 10 and 5 Players Market Share by Drug Metabolism and Pharmacokinetics (DMPK) Revenue in 2025
Figure 21. North America Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Type (2021-2026)
Figure 22. North America Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Application (2021-2026)
Figure 23. Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Type (2021-2026)
Figure 24. Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Application (2021-2026)
Figure 25. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Type (2021-2026)
Figure 26. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Application (2021-2026)
Figure 27. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Type (2021-2026)
Figure 28. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Application (2021-2026)
Figure 29. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Type (2021-2026)
Figure 30. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Application (2021-2026)
Figure 31. Eurofins Discovery Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
Figure 32. Inotiv Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
Figure 33. Evotec Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
Figure 34. Sai Life Sciences Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
Figure 35. Sygnature Discovery Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
Figure 36. WuXi AppTec Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
Figure 37. Hangzhou Tigermed Consulting Co Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
Figure 38. Q2 Solutions Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
Figure 39. Jubilant Biosys Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
Figure 40. Frontage Laboratories Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
Figure 41. Invitrocue Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
Figure 42. Creative Biolabs Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
Figure 43. CrownBioscience Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
Figure 44. Agilent Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
Figure 45. H3D Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
Figure 46. LABCORP Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
Figure 47. Bioduro-Sundia Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
Figure 48. Allucent Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2021-2026)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed